February 7, 2017 | Israeli bio-medical start-up Laminate Medical Technologies, which is developing a blood vessel support device implanted in patients needing dialysis, has announced it has raised $8 million in a B round of capital raising. This round brings the total investment in the company to $13 million. A number of European funds took part in the current round, as well as the Chinese pharma giant Haisco. The company’s existing investors are private investors, including Nava and Yehuda Zisapel, Zohar Gilon, Eri Steimatzky, Henit Vitos, Ari Raved, and a grant from the Chief Scientist in the Ministry of the Economy. Laminate was founded in 2012 by Tammy Gilon, who is the company’s CEO, and Dr. Eyal Orion, and started out in the Rad-Biomed incubator.